- Home
- MGIH vs EKSO Comparison
MGIH vs EKSO Comparison
Compare MGIH & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGIH
- EKSO
- Stock Information
- Founded
- MGIH 1978
- EKSO 2005
- Country
- MGIH Hong Kong
- EKSO United States
- Employees
- MGIH N/A
- EKSO N/A
- Industry
- MGIH Publishing
- EKSO Medical/Dental Instruments
- Sector
- MGIH Consumer Discretionary
- EKSO Health Care
- Exchange
- MGIH Nasdaq
- EKSO Nasdaq
- Market Cap
- MGIH 18.7M
- EKSO 19.1M
- IPO Year
- MGIH 2023
- EKSO N/A
- Fundamental
- Price
- MGIH $1.63
- EKSO $0.75
- Analyst Decision
- MGIH
- EKSO Strong Buy
- Analyst Count
- MGIH 0
- EKSO 2
- Target Price
- MGIH N/A
- EKSO $5.50
- AVG Volume (30 Days)
- MGIH 15.1K
- EKSO 104.6K
- Earning Date
- MGIH 11-22-2024
- EKSO 10-28-2024
- Dividend Yield
- MGIH N/A
- EKSO N/A
- EPS Growth
- MGIH N/A
- EKSO N/A
- EPS
- MGIH N/A
- EKSO N/A
- Revenue
- MGIH $38,530,773.00
- EKSO $17,682,000.00
- Revenue This Year
- MGIH N/A
- EKSO $1.11
- Revenue Next Year
- MGIH N/A
- EKSO $38.63
- P/E Ratio
- MGIH N/A
- EKSO N/A
- Revenue Growth
- MGIH N/A
- EKSO 4.12
- 52 Week Low
- MGIH $0.89
- EKSO $0.72
- 52 Week High
- MGIH $9.57
- EKSO $3.13
- Technical
- Relative Strength Index (RSI)
- MGIH 51.33
- EKSO 28.02
- Support Level
- MGIH $1.52
- EKSO $0.72
- Resistance Level
- MGIH $1.69
- EKSO $0.92
- Average True Range (ATR)
- MGIH 0.10
- EKSO 0.07
- MACD
- MGIH 0.01
- EKSO -0.01
- Stochastic Oscillator
- MGIH 80.00
- EKSO 10.83
About MGIH Millennium Group International Holdings Limited
Millennium Group International Holdings Ltd is a paper-based packaging solutions supplier. It offers paper-based inner and outer packaging products which can be broadly categorized into packaging products and corrugated products.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.